ID

14231

Descrizione

Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain; ODM derived from: https://clinicaltrials.gov/show/NCT00287248

collegamento

https://clinicaltrials.gov/show/NCT00287248

Keywords

  1. 05/04/16 05/04/16 -
Caricato su

5 aprile 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Alzheimer Disease NCT00287248

Eligibility Alzheimer Disease NCT00287248

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
the participant is 50 years or older.
Descrizione

age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
written informed consent is obtained.
Descrizione

informed consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
participants have a clinical diagnosis of alzheimer's disease based on national institute of neurological and communicative disorders and stroke/alzheimer's disease and related disorders association (nincds/adra) criteria.
Descrizione

alzheimers disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0002395
mini-mental status exam score > 16 and < 25.
Descrizione

mini mental status exam score

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2225229
patients have a diagnosis of probable ad for < 3 years prior to screening.
Descrizione

alzheimers disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0002395
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
the subject has signs or symptoms of another neurodegenerative disease including parkinson's disease, diffuse lewy body dementia, or history of significant cerebrovascular disease.
Descrizione

neurodegenerative disease; Parkinson Disease; lewy body dementia; cerebrovascular disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0524851
UMLS CUI [2]
C0030567
UMLS CUI [3]
C0752347
UMLS CUI [4]
C0007820
subjects with an iodine allergy.
Descrizione

iodine allergy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0571818
the subject has a clinically significant clinical laboratory value and/or medical or psychiatric illness.
Descrizione

psychiatric illness

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004936
the subject has any disorder that may interfere with drug absorption distribution, metabolism, or excretion (including gastrointestinal surgery).
Descrizione

Compliance behavior Limited Comorbidity; drug absorption; gastrointestinal surgery

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
UMLS CUI [2]
C0678745
UMLS CUI [3]
C0524722
the subject has evidence of clinically significant thyroid disease, gastrointestinal, cardiovascular, hepatic, renal, hematologic, neoplastic, endocrine, neurologic, immunodeficiency, pulmonary, or other medical or psychiatric disorder.
Descrizione

thyroid disease; gastrointestinal disease; cardiovascular disease; hepatic disease; renal disease; hematologic disease; neoplastic disease; psychiatric disorder

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0040128
UMLS CUI [2]
C0017178
UMLS CUI [3]
C0007222
UMLS CUI [4]
C0023895
UMLS CUI [5]
C0022658
UMLS CUI [6]
C0018939
UMLS CUI [7]
C1882062
UMLS CUI [8]
C0004936
the subject has received an investigational drug within 60 days before the screening visit.
Descrizione

investigational drug

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0013230
pregnancy
Descrizione

pregnancy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961

Similar models

Eligibility Alzheimer Disease NCT00287248

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
the participant is 50 years or older.
boolean
C0001779 (UMLS CUI [1])
informed consent
Item
written informed consent is obtained.
boolean
C0021430 (UMLS CUI [1])
alzheimers disease
Item
participants have a clinical diagnosis of alzheimer's disease based on national institute of neurological and communicative disorders and stroke/alzheimer's disease and related disorders association (nincds/adra) criteria.
boolean
C0002395 (UMLS CUI [1])
mini mental status exam score
Item
mini-mental status exam score > 16 and < 25.
boolean
C2225229 (UMLS CUI [1])
alzheimers disease
Item
patients have a diagnosis of probable ad for < 3 years prior to screening.
boolean
C0002395 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
neurodegenerative disease; Parkinson Disease; lewy body dementia; cerebrovascular disease
Item
the subject has signs or symptoms of another neurodegenerative disease including parkinson's disease, diffuse lewy body dementia, or history of significant cerebrovascular disease.
boolean
C0524851 (UMLS CUI [1])
C0030567 (UMLS CUI [2])
C0752347 (UMLS CUI [3])
C0007820 (UMLS CUI [4])
iodine allergy
Item
subjects with an iodine allergy.
boolean
C0571818 (UMLS CUI [1])
psychiatric illness
Item
the subject has a clinically significant clinical laboratory value and/or medical or psychiatric illness.
boolean
C0004936 (UMLS CUI [1])
Compliance behavior Limited Comorbidity; drug absorption; gastrointestinal surgery
Item
the subject has any disorder that may interfere with drug absorption distribution, metabolism, or excretion (including gastrointestinal surgery).
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0678745 (UMLS CUI [2])
C0524722 (UMLS CUI [3])
thyroid disease; gastrointestinal disease; cardiovascular disease; hepatic disease; renal disease; hematologic disease; neoplastic disease; psychiatric disorder
Item
the subject has evidence of clinically significant thyroid disease, gastrointestinal, cardiovascular, hepatic, renal, hematologic, neoplastic, endocrine, neurologic, immunodeficiency, pulmonary, or other medical or psychiatric disorder.
boolean
C0040128 (UMLS CUI [1])
C0017178 (UMLS CUI [2])
C0007222 (UMLS CUI [3])
C0023895 (UMLS CUI [4])
C0022658 (UMLS CUI [5])
C0018939 (UMLS CUI [6])
C1882062 (UMLS CUI [7])
C0004936 (UMLS CUI [8])
investigational drug
Item
the subject has received an investigational drug within 60 days before the screening visit.
boolean
C0013230 (UMLS CUI [1])
pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial